IL-10 Exerts Suppressive and Enhancing Effects on Antifungal Activity of Mononuclear Phagocytes Against Aspergillus fumigatus

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 322-329

  Roilides, Emmanuel ^a,b   Dimitriadou, Anastasia ^a   Kadiltsoglou, Isaac ^a   Sein, Tin ^b   Karpouzas, John ^a   Pizzo, Philip A ^b   Walsh, Thomas J ^a,b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CYTOKINE; IMMUNOLOGICAL ADJUVANT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; SUPEROXIDE;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PHAGOCYTE; PHAGOCYTOSIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DRUG SYNERGISM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; PHAGOCYTES; PHAGOCYTOSIS; SUPEROXIDES;

EID: 0030639089     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Young, R. C., J. E. Bennett, C. L. Vogel, P. P. Carbone and V. T. DeVita. 1970. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 49:147.
2. Walsh, T. J. 1990. Invasive aspergillosis in patients with neoplastic diseases. Semin. Respir. Infect. 5:111.
3. Cohen, M. S., R. E. Isturiz, H. L. Malech, R. K. Root, C. M. Wilfert, L. Gutman, and R. H. Buckley. 1981. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. Am. J. Med. 71:59.
4. Denning, D. W., S. E. Follansbee, M. Scolaro, S. Norris, H. Edelstein, and D. A. Stevens. 1991. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 324:654.
5. Rowen, J. L., A. G. Correa, D. M. Sokol, H. K Hawkins, M. L. Levy, and M. S. Edwards. 1992. Invasive aspergillosis in neonates: report of five cases and literature review. Pediatr. Infect. Dis. J. 11:576.
6. Weinberger, M., I. Elattar, D. Marshall, S. M. Steinberg, R. L. Redner, N. S. Young, and P. A. Pizzo. 1992. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine 71:24.
7. Brooks, R. G., J. M. Hofflin, S. W. Jamieson, E. B. Stinson, and J. S. Remington. 1985. Infectious complications in heart-lung transplant recipients. Am. J. Med. 79:412.
8. Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1993. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine 72: 78.
9. Waldorf, A. R., and R. D. Diamond. 1989. Aspergillosis and mucormycosis. In Immunology of the Fungal Diseases. R. A. Cox, ed. CRC Press, Boca Raton, FL, p. 29.
10. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69:617.
11. Waldorf, A. R., S. Levitz, and R. D. Diamond. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis. 150:752.
12. Levitz, S., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154:483.
13. Diamond, R. D., R. Krzesicki, B. Epstein, and W. Jao. 1978. Damage to hyphal forms of fungi by human leukocytes in vitro: a possible host defense mechanism in aspergillosis and mucormycosis. Am. J. Pathol. 91:313.
14. Polak-Wyss, A. 1991. Protective effect of human granulocyte colony-stimulating factor on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 34:205.
15. Rex, J. H., J. E. Bennett, J. I. Gallin, H. L. Malech, E. S. Decarlo, and D. A. Melnick. 1991. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J. Infect. Dis. 163:849.
16. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J. Infect. Dis. 170:894.
17. Roilides, E., T. Sein, A. Holmes, C. Blake, P. A. Pizzo, and T. J. Walsh. 1995. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172.1028.
18. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Granulocyte colony-stimulating factor and interferon-γ enhance the oxidative responses and the damage caused by human neutrophils to Aspergillus fumigatus hyphae in vitro. Infect. Immun. 61:1185.
19. Walsh, T., C. Gonzalez, C. Lyman, S. Lee, C. Del Guercio, A. Gehrt, T. Sein, E. Roilides, R. Schafele, A. Francesconi, and P. Pizzo. 1994. Human recombinant macrophage colony stimulating factor augments pulmonary host defense against Aspergillus fumigatus (Abstr. F-27). In Abstracts of the Annual Meeting of the American Society of Microbiology. American Society for Microbiology, Washington, DC, p. 593.
20. Mosmann, T. R., and K. W. Moore. 1991. The role of IL-10 in crossregulation of Th1 and Th2 responses. Immunol. Today 12:A49.
21. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. Il-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
22. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
23. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
24. Taga, K., and G. Tosato. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143.
25. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin-10. J. Exp. Med. 174:1549.
26. Ralph, P., I. Nakoinz, A. Sampson-Johannes, S. Fong, D. Lowe, H.-Y. Min, and L. Lin. 1992. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol. 148:808.
27. Tripp, C. S., S. F. Wolf, and E. R. Uranue. 1993. Interleukin 12 and tumor necrosis factor a are costimulators of interferon-γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
28. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
29. de Waal Malefyt, R., H. Yssel, M.-G. Roncarolo, H. Spits, and J. E. de Vries. 1992. Interleukin-10. Curr. Opin. Immunol. 4:314.
30. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224.
31. Hsu, D. H., K. W. Moore, and H. Spits. 1992. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int. Immunol. 4:563.
32. Schandene, L., C. Gerard, A. Crusiaux, D. Abramowicz, T. Velu, and M. Goldman. 1993. Interleukin-10 inhibits OKT3-induced cytokine release: in vitro comparison with pentoxifylline. Transplant. Proc. 25(Suppl 1):55.
33. Oswald, I. P., R. T. Gazzinelli, A. Sher, and S. L. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578.
34. Sieling, P. A., J. S. Abrams, M. Yamamura, P. Salgame, B. R. Bloom, T. H. Rea, and R. L. Modlin. 1993. Immunosuppressive roles for IL-10 and IL-4 in human infection. J. Immunol. 150:5501.
35. Cenci, E., L. Romani, A. Mencacci, R. Spaccapelo, E. Schiaffella, P. Puccetti, and F. Bistoni. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23:1034.
36. Abrahamsen, T. G., C. S. Carter, E. J. Read, M. Rubin, H. G. Goetzman, E. F. Lizzio, Y. L. Lee, M. Hanson, P. A. Pizzo, and T. Hoffman. 1991. Stimulatory effect of counterflow centrifugal elutriation in large-scale separation of peripheral blood monocytes can be reversed by storing the cells at 37 degrees C. J. Clin. Apheresis 6:48.
37. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97:77.
38. Levitz, S. M., and R. D. Diamond. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J. Infect. Dis. 152:938.
39. Te Velde, A. A., J. P. G. Klomp, B. A. Yard, J. E. de Vries, and C. G. Figdor. 1988. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. J. Immunol. 140:1548.
40. Murray, H. W. 1990. Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. Diagn. Microbiol. Infect. Dis. 13:411.
41. Chomarat, P., M.-C. Rissoan, J. Banchereau, and P. Miossec. 1993. Interferon γ inhibits interleukin 10 production by monocytes. J. Exp. Med. 177:523.
42. Hart, P. H., M. J. Ahern, M. D. Smith, and J. J. Finlay-Jones. 1995. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 84:536.
43. Vieth, M., A. Will, K. Schroppel, M. Rollinghoff, and A. Gessner. 1994. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages. Scand. J. Immunol. 40:403.
44. Nabioullin, R., S. Sone, K. Mizuno, S. Yano, Y. Nishioka, T. Haku, and T. Ogura. 1994. Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J. Leukocyte Biol. 53:437.
45. Schaffner, A. 1994. Macrophage-Aspergillus interactions. Immunol. Ser. 60:545.
46. Lortholary, O., M. C. Meyohas, B. Dupont, J. Cadranel, D. Salmon-Ceron, D. Peyramond, and D. Simonin. 1993. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases: French Cooperative Study Group on aspergillosis in AIDS. Am. J. Med. 95:177.
47. Minamoto, G. Y., T. F. Barlam, and N. J. Vander Els. 1992. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 14:66.
48. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. P. Blatt, C. W. Hendrix, A. Sher, R. L. Coffman, and G. M. Shearer. 1994. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:768.
49. Brodie, S. J., V. G. Sasseville, K. A. Reimann, M. A. Simon, P. K. Sehgal, and D. J. Ringler. 1994. Macrophage function in simian AIDS: killing defects in vivo are independent of macrophage infection, associated with alterations in Th phenotype, and reversible with IFN-γ. J. Immunol. 153:5790.
50. Binder, R. E., L. J. Faling, R. D. Pugatch, C. Mahasaen, and G. L. Snider. 1982. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 61:109.
51. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. NY Acad. Sci. 685:713.
52. Te Velde, A. A., R. de Waal Malefyt, R. J. F. Huijbens, J. E. de Vries, and C. G. Figdor. 1992. Il-10 stimulates monocyte FcγR surface expression and cytotoxic activity: distinct regulation of antibody-dependent cellular cytotoxicity by IFN-γ. IL-4, and IL-10. J. Immunol. 149:4048.
53. Roilides, E., C. Carter, A. Holmes, C. Blake, P. A. Pizzo, and T. J. Walsh. 1992. Interferon γ and granulocyte-macrophage colony-stimulating factor enhance the fungicidal activity of normal and dexamethasone-treated elutriated human monocytes against Aspergillus (Abstr. No. 65). In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC, p. 121.
54. Romani, L., P. Puccetti, A. Mencacci, E. Cenci, R. Spaccapelo, L. Tonnetti, U. Grohmann, and F. Bistoni. 1994. Neutralization of IL-10 upregulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152:3514.